🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 study of gemcitabine + high-dose chemotherapy followed by...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2001-09
Trial ID
NCT00388349
Treatments Being Tested
This is a phase I study. The purpose of this study is to see if it is safe ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-01-05
Trial ID
NCT02650648
Treatments Being Tested
The purpose of this study is to determine whether stem cells collected from...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2015-02-11
Trial ID
NCT02167958
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
The primary objective of this study is to estimate the efficacy of axicabta...
Status
Completed
Location
Banner Health MD Anderson Cancer Center
Start Date
2019-01-29
Trial ID
NCT03761056
Treatments Being Tested
The purpose of this Phase 2 randomized study is to evaluate the efficacy an...
Status
Completed
Location
Wilhelminenspital-1
Start Date
2007-10
Trial ID
NCT00531453
The purpose of this study is to evaluate the safety and effectiveness of bo...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00833560
Treatments Being Tested
Clinical information of children with ANCA-associated nephritis admitted to...
Status
Unknown
Location
Children's Hospital of Chongqing Medical University
Start Date
2023-01-01
Trial ID
NCT05969522
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Cancer Center and Beckman Research Institute, City of Hope
Start Date
1999-05-18
Trial ID
NCT00003927
This is a multi-institutional Phase I/II study of an allogeneic KIR-HLA mis...
Status
Recruiting
Location
Mark Juckett, MD
Start Date
2026-05-08
Trial ID
NCT07591649
Treatments Being Tested